🔗 Share this article

The Nobel Prize in medical science has been awarded for transformative discoveries that illuminate how the body's defense network targets harmful pathogens while sparing the body's own cells.

A trio of renowned researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this honor.

Their work uncovered specialized "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the organism.

The discoveries are now enabling innovative therapies for immune disorders and malignancies.

These winners will divide a monetary award valued at 11m SEK.

Crucial Findings

"The research has been essential for comprehending how the immune system functions and the reason we do not all develop severe self-attack conditions," stated the chair of the award panel.

This trio's research address a core mystery: How does the defense system defend us from countless infections while keeping our healthy cells unharmed?

Our immune system employs white blood cells that search for signs of disease, even pathogens and bacteria it has never encountered.

These cells employ sensors—called recognition units—that are generated randomly in a vast number of variations.

This provides the defense network the ability to fight a broad range of threats, but the unpredictability of the process unavoidably produces immune cells that may target the host.

Security Guards of the Immune System

Researchers previously understood that a portion of these problematic white blood cells were eliminated in the thymus—where white blood cells mature.

This year's award recognizes the discovery of T-reg cells—described as the immune system's "peacekeepers"—which travel through the system to neutralize other immune cells that attack the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

A Nobel panel stated, "The findings have laid the foundation for a new field of research and spurred the development of innovative therapies, for instance for tumors and immune disorders."

Regarding malignancies, regulatory T-cells block the system from fighting the tumor, so studies are aimed at lowering their numbers.

In autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is not under attack. A comparable method could also be effective in reducing the chances of transplanted organ failure.

Pioneering Experiments

Professor Shimon Sakaguchi, from a Japanese institution, performed experiments on mice that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that introducing immune cells from other mice could prevent the disease—implying there was a system for blocking immune cells from attacking the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and humans that led to the discovery of a gene vital for the way regulatory T-cells operate.

"The pioneering research has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," said a leading physiology expert.

"This work is a remarkable illustration of how basic biological study can have broad consequences for human health."